Big Easy Weight Loss vs Effecty

Neither Big Easy Weight Loss nor Effecty has an FDA warning letter on record. On compounded semaglutide injection, Effecty costs $112 less a year at standing rates: $170 a month against $179.37 a month at Big Easy Weight Loss.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Big Easy Weight Loss / Effecty

Big Easy Weight Loss logo

Big Easy Weight Loss

8.3/10

Effecty logo

Effecty

8.1/10

FDA warning letters
None on record
None on record
Pharmacy
  • Seven Cellstype not stated
  • Hallandale503A
  • OptioRx503A
  • and 1 more
None named in our record
Lowest standing price
$179.37/moCompounded semaglutide injection
$170/moCompounded semaglutide injection
States
All 50 states and DC
All 50 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026

Neither Big Easy Weight Loss nor Effecty pays us. Links to them earn nothing. Scores: Big Easy Weight Loss 8.3, Effecty 8.1. How we are paid

What the record shows

  1. 01

    Neither Big Easy Weight Loss nor Effecty has an FDA warning letter on record.

  2. 02

    Big Easy Weight Loss names four pharmacies. Effecty names no compounding pharmacy in our record.

  3. 03

    On compounded semaglutide injection, Effecty costs $112 less a year at standing rates: $170 a month against $179.37 a month at Big Easy Weight Loss.

  4. 04

    Only Effecty lists a price for brand-name semaglutide pen and brand-name tirzepatide pen.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Big Easy Weight Loss

Effecty

Compounded semaglutide injection

$179.37/mo

$2,152 a year

$170/moLower

$2,040 a year

Compounded tirzepatide injection

$169.94/mo

prepaid plan; not compared

$235/mo

$2,820 a year

Brand-name semaglutide pen
Not sold or not priced

$1,300/mo

$15,600 a year

Brand-name tirzepatide pen
Not sold or not priced

$1,300/mo

$15,600 a year

Price includes
Medication, clinician visits, shipping
Medication, clinician visits, shipping
Minimum term
Not stated
Month-to-month plan has none; longer plans are paid in advance
Refunds
Not stated
No refunds of subscription fees already paid; all sales are final

Read off each seller’s own pages. Big Easy Weight Loss: October 17, 2026. Effecty: October 17, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Big Easy Weight Loss

8.3/10
  • Names its compounding pharmacy

The case for Effecty

8.1/10
  • $112 a year less on compounded semaglutide injection
  • Sells brand-name semaglutide pen and brand-name tirzepatide pen, which Big Easy Weight Loss does not price
  • Names no compounding pharmacy

Scores

Big Easy Weight Loss 8.3 · Effecty 8.1 out of 10. Six weighted parts.

Value25%

5.7A
vs
B
6.1

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

10.0A
vs
B
7.5

Accessibility10%

10.0A
vs
B
10.0

Support10%

7.0A
vs
B
7.0

The score is the same formula for every seller. Payment does not enter it. Method

Big Easy Weight Loss vs Effecty: questions

Neither Big Easy Weight Loss nor Effecty has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Big Easy Weight Loss names four pharmacies. Effecty names no compounding pharmacy in our record. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
Effecty, by $112 a year at standing rates. Big Easy Weight Loss: $179.37 a month, about $2,152 a year. Effecty: $170 a month, about $2,040 a year.
Neither Big Easy Weight Loss nor Effecty pays us. Links to them earn nothing. Scores: Big Easy Weight Loss 8.3, Effecty 8.1.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks